Dissolution of the exclusive right for sale of Reveal® DX

April 22, 2013
Asahi Kasei Corp.

Asahi Kasei Corp. and Medtronic Japan Co., Ltd. have reached a decision to end their alliance on April 26, 2013, terminating Asahi Kasei’s exclusive rights for domestic Japanese sale of Reveal® DX insertable cardiac monitor. Rights for sale in Japan will revert to Medtronic Japan, the Marketing Authorization Holder of Reveal® DX, on April 27, 2013.

Asahi Kasei will utilize the experience gained through the sale of Reveal® DX to enhance service while further developing business in the field of critical care, with defibrillators and other products of ZOLL Medical Corporation.


Adobe Readeris required to view these PDF files.

page top